Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
At the end of the session, you will be able to:
Over the last decade as the requirements for evidence to support the various dimensions of value assessment of medicines have strengthened and the breadth of audiences has increased, Medical Affairs is realizing more potential and bringing together its capabilities for strategy, science, and communication in powerful ways. In the rapidly evolving regulatory, technological, and scientific environment, the Medical Affairs function is uniquely positioned to coordinate the identification, prioritization, strategic planning, execution and communication of the broad variety of high-quality evidence necessary to fulfill unmet needs of clinicians, payers, reimbursement agencies, policy makers, advocacy groups, and patients.
This Standard and Guidance is intended to inform learners about the Evidence Generation function, strategic direction, and operations across multiple geographies.
Customer engagements for Medical Affairs has evolved rapidly post COVID-19. Hybrid is the future and that brings with it new challenges, most notably in sustaining engagements with the KOLs to become unbiased scientific partners of choice. As a result, there have been shifts in strategies: newer roles, newer stakeholders to be engaged, and more data and information collected.
There is no one-size-fits-all approach. The intent of this webinar will be to have a discussion on which strategies are working, and how leading companies are defining success for field medical teams in hybrid engagements.
AI Application in Medical Affairs – Advanced Course
This course includes
What you will learn?
Course description
This comprehensive course is tailored to professionals in the pharmaceutical, biotechnology, and medical device industries who work in Medical Affairs functions. It addresses the impact of technology and automation on Medical Affairs in the post–COVID-19 era, which has been accelerated by the pandemic.
This curriculum delves into the utilization of AI in the creation of personalized content, management of medical queries, and prediction of customer engagement pathways.
Additionally, it examines the use of AI in MLR review processes to allow for a more strategic allocation of resources and highlights current AI applications utilized in MLR reviews.
Furthermore, this curriculum explores the application of AI in personalizing customer interactions and utilizing next-best actions, content affinity, and channel affinity in Medical Affairs interactions, as well as AI’s role in generating insights.
Our on-demand content, which includes animations and rich graphics, is presented in a clear and concise manner, making it easy to understand and apply in real-world scenarios. Upon successful completion of the Certification Quiz, a downloadable version of this curriculum will be made available to users..
Learning activities/assessments: eLearning self-paced modules, knowledge checks, and a brief pre- and post-test
Approximate time to complete the activity: 120 minutes
Prerequisites: The eLearning module “Artificial Intelligence Foundations for Medical Affairs” is highly recommended.
Audience: Intermediate-level content for Medical Affairs professionals who have digital experience
Credits: As an IACET Accredited Provider, Medical Affairs Professional Society offers IACET CEUs for its learning events that comply with the ANSI/IACET Continuing Education and Training Standard. MAPS is authorized by IACET to offer 0.2 CEUs for this program.
Participants/attendees must complete 100% of the program and receive a minimum of 70% on the post program assessment.
At the conclusion of this online learning activity, participants should be able to:
1. Recall the impact of technology and automation across Medical Affairs in a post-Covid-19 world especially accelerated due to the pandemic
2. Articulate the potential business cases for AI within the Medical Affairs function
3. Describe the use of AI in modular content creation to deliver personalized targeted content
4. Explain how AI can help in the content supply chain and query management
5. Identify how the integration of AI and data sources predicts an ideal customer engagement pathway
6. Explain the need for AI in MLR review to allow reviewers to do more strategic work
7. List a few examples of AI applications in MLR review
8. Explain the role of AI in advanced MI portal search
9. Discuss the importance of conversational AI in customer interactions
10. Describe how AI can help in insight generation
11. List a few use cases of insight generation using AI in Medical Affairs
All industries are rushing to harness rich data in order to drive progress, but how can the many data sources help Medical Affairs to show impact and drive improved patient outcomes?
In part three of this four-part series, we will discuss:
This Webinar series explores the fundamental concept of big data in Medical Affairs, from which sources can we retrieve this, what are the broader considerations when utilizing data in health and what impact this can have on our organizations, physicians, and patients, now and in the future. These presentations will feature real-world cases that are relevant to regional and country Medical Affairs leaders, in order to highlight long-term aspirational and short-term tangible projects.
While the value of patient engagement is increasingly recognised in the clinical and launch phases of drug development, it is still a relatively new concept to involve patients in the early discovery phase. By understanding the burden of disease and patient’s aspirations for new treatments from the outset, pharma companies can ensure they are developing medicines that matter to patients. As experts in the disease area and therapeutic landscape, Medical Affairs are well placed to initiate and develop effective patient partnerships to ensure that the patient voice is incorporated during early discovery and beyond.
In this webinar we will explore practical approaches to engaging patients in early development, introducing key resources and discussing best practices. These discussions will be tailored to meet the needs of all Medical Affairs colleagues, regardless of experience.
Medical Information is a critical conduit with healthcare providers who interact with field sales or scientific professionals or who seek scientific information independently. In this customer-facing and customer-focused capacity, Medical Information is the “face” of the manufacturer to many external customers and serves to facilitate the safe and effective use of the marketed products. Medical Information has a significant role in supporting the information needs of HCPs, patients, and caregivers through the provision of medical information in response to unsolicited questions about the manufacturer’s products and strives to provide excellent customer service based on the customer’s expectations through a variety of channels. MedInfo also partners with internal business functions, including, but not limited to: Medical Affairs, Pharmaceutical and Clinical Development, Quality Assurance, Manufacturing, Publication Planning, Safety, Business Technology, Finance, Legal, Regulatory, and Commercial/Marketing.
This Standard and Guidance is intended to inform learners about the Medical Information (MI) function, strategic direction, and operations across multiple geographies.
Medical Affairs professionals want to share Real-World Evidence (RWE) about drug products with payers, patient advocates and others, but communications about drug products are highly regulated. Federal laws, including FDAMA Section 114, FDA guidance materials and FDA enforcement actions all provide insight into the types of communications FDA will and will not accept. This presentation will provide insights into the types of communications that FDA has indicated are or are not permissible, and the uncertainties that still remain.
In late January, MAPS published an article by Rahul Mandlik describing the use of ChatGPT in Medical Affairs. The result was a LinkedIn Discussion with over 40,000 views in its first 6 days. During this webinar, thought leaders in this space vision how ChatGPT may augment or, at times, undermine the practice of Medical Affairs in areas such as Medical Information, Omnichannel engagement and more. This is your chance to engage in the discussion of this absolutely cutting-edge topic. Is ChatGPT just another techno-fad? Will it fundamentally transform the Medical Affairs? What are the opportunities and dangers of this new technology? Bring your questions and join us for this interactive session.
All industries are rushing to harness rich data in order to drive progress, but how can the many data sources help Medical Affairs to show impact and drive improved patient outcomes?
In part two of this four part series, we will discuss:
This Webinar series explores the fundamental concept of big data in Medical Affairs, from which sources can we retrieve this, what are the broader considerations when utilizing data in health and what impact this can have on our organizations, physicians, and patients, now and in the future. These presentations will feature real world cases that are relevant to regional and country Medical Affairs leaders, in order to highlight long-term aspirational and short-term tangible projects.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.